Apitope Technology Ltd

Apitope is a European biotech company focusing on the discovery and development of revolutionary disease modifying therapies for treating autoimmune and allergic diseases, including multiple sclerosis, and Graves’ disease.

The Company is developing potential therapies intended to selectively treat the underlying cause of a range of autoimmune diseases rather than simply treat the disease symptoms or non-specifically suppress the whole immune system.

Contact: Professor David Wraith, Department of Pathology and Microbiology
Email: d.c.wraith@bristol.ac.uk